Objectives To identify the risks and benefits of clozapine‑lithium co-prescription. Methods
Articles published in English or French were identified with a MEDLINE, Web of Sciences …

Background Clozapine is a gold standard treatment for treatment-resistant schizophrenia.
However, the patients' and caregivers' perception and their experience with clozapine has …

Background Pharmacovigilance studies indicate clozapine history is marked by adverse
drug reactions (ADRs). Objective In a 2021 article, the United Kingdom (UK) had> 90% of …

Escaping the Long Shadow Cast by Agranulocytosis: Reflection... : Journal of Clinical
Psychopharmacology Escaping the Long Shadow Cast by Agranulocytosis: Reflections on …

Introduction We aimed to synthesize the information on the risks and benefits of clozapine
prescription for resistant challenging behavior in persons with neurodevelopmental …

Introduction International reports indicate that clozapine is under prescribed. Yet, this has
not been explored in Southeast European (SEE) countries. This cross-sectional study …

Background Clozapine is the most effective antipsychotic for patients with treatment-resistant
schizophrenia (TRS), however, it remains widely under-utilized in clinical practice. To date …

Introduction Antiseizure medication (ASM) add-on to clozapine may be efficient to target
clozapine-resistant mood or psychotic symptoms or clozapine-related adverse drug …

Abstract Background and Objectives Despite the evidence that no other antipsychotic is
effective as clozapine for the treatment of resistant schizophrenia, it is associated with …

Aim: To review genetic biomarkers of agranulocytosis and efficacy with clozapine as a
screening tool for the safe and effective use of clozapine. Methods: A PubMed search was …